Aktive Positionen von Jason Auerbach
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOELIS & COMPANY | Corporate Officer/Principal | 25.04.2023 | - |
Karriereverlauf von Jason Auerbach
Ehemalige bekannte Positionen von Jason Auerbach
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Direktor der Forschung - Eigenkapital | 01.08.2021 | 01.04.2023 |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Director of Research - Equity | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOELIS & COMPANY | Finance |
| Private Unternehmen | 1 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
- Börse
- Insiders
- Jason Auerbach
- Erfahrung
